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Background
The number of children born to HIV seropositive mothers
in Romania has increased in the past few years, since the
patients from the ’90s cohort have reached reproductive
age and new cases of sexually or drug infected women
have emerged.
Case report
We present the case of a 9 year, 6 month old girl, diag-
nosed with HIV at the age of 2, right after the death of her
HIV seropositive father (later the mother was also diag-
nosed with HIV). For more than 7 years the mother did
not administer the child the antiretroviral treatment that
she was supplied with. In January 2013, after the mother’s
death, the patient’s health worsened. She was admitted for
multiple opportunistic associated infections, but, despite
the complex therapeutic treatment administered, the
evolution was not favorable.
Conclusion
Adherence to medical care and antiretroviral therapy of a
seropositive child is still a challenge and it actually
involves the adherence of both parent and child. Because
of prolonged treatment abandonment, the management
of HIV infection associated with severe opportunistic
infections is extremely difficult, due to lack of treatment
response of an exhausted organism, limited therapeutic
options, drug interactions, and adverse events.
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